Helen F. Galley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Helen F. Galley has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Damon A. Lowes
Institute of Medical Sciences, University of Aberdeen, Aberdeen AB41 8TJ, UK
14 shared publications Nigel R. Webster
Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition University of Aberdeen Aberdeen UK
12 shared publicationsN. R. Webster
Anaesthesia and Intensive Care , Institute of Medical Sciences, University of Aberdeen , Foresterhill, Aberdeen AB25 2ZD , UK
7 shared publications- Lesley A. Colvin
Chronic Pain Research Group, Division of Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK
4 shared publications Lee Allen
Intensive Care Unit, Aberdeen Royal Infirmary NHS Grampian Aberdeen UK
3 shared publicationsN.R. Webster
Academic Unit of Anaesthesia and Intensive Care, School of Medicine & Dentistry and
3 shared publications
Latest Publications
- Open Access
- 14 February 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (4) , 725-734
Melatonin treatment has consistent but transient beneficial effects on sleep measures and pain in patients with severe chronic pain: the DREAM–CP randomised controlled trial
- 14 February 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (4) , 725-734
Open AccessMelatonin treatment has consistent but transient beneficial effects on sleep measures and pain in patients with severe chronic pain: the DREAM–CP randomised controlled trial
- Open Access
- 11 September 2022
- Published by Wiley in Journal of Pineal Research
- Vol. 73 (4) , e12830
Dose assessment of melatonin in sepsis (DAMSEL2) study: Pharmacokinetics of two doses of oral melatonin in patients with sepsis
Sepsis is defined as a dysregulated host response to infection, and high‐dose melatonin has been proposed as a treatment due to its antioxidant and anti‐inflammatory properties. However, there are no data describing the pharmacokinetics of high‐dose oral melatonin in critically ill patients. We undertook an open‐label trial to determine the tolerance of melatonin administration in these patients and pharmacokinetic analysis, to inform a planned randomised controlled trial. Two cohorts of critically ill patients with sepsis due to community‐acquired pneumonia received either 20 or 50 mg oral melatonin liquid as a single dose. Blood samples and clinical measures were analysed over the next 24 h. Melatonin was well tolerated and there were no adverse events. Pharmacokinetic modelling showed that a semiphysiological model, which incorporates saturable first‐pass hepatic extraction, was a good fit for our data. Maximum levels of melatonin were extremely high in patients receiving the 50 mg dose and levels of the major metabolite were much lower than expected and not different from those seen after 20 mg, suggesting saturation at the higher dose. We conclude that 20 mg seems a suitable dose of liquid melatonin in patients with sepsis.
- 11 September 2022
- Published by Wiley in Journal of Pineal Research
- Vol. 73 (4) , e12830
Open AccessDose assessment of melatonin in sepsis (DAMSEL2) study: Pharmacokinetics of two doses of oral melatonin in patients with sepsis
Sepsis is defined as a dysregulated host response to infection, and high‐dose melatonin has been proposed as a treatment due to its antioxidant and anti‐inflammatory properties. However, there are no data describing the pharmacokinetics of high‐dose oral melatonin in critically ill patients. We undertook an open‐label trial to determine the tolerance of melatonin administration in these patients and pharmacokinetic analysis, to inform a planned randomised controlled trial. Two cohorts of critically ill patients with sepsis due to community‐acquired pneumonia received either 20 or 50 mg oral melatonin liquid as a single dose. Blood samples and clinical measures were analysed over the next 24 h. Melatonin was well tolerated and there were no adverse events. Pharmacokinetic modelling showed that a semiphysiological model, which incorporates saturable first‐pass hepatic extraction, was a good fit for our data. Maximum levels of melatonin were extremely high in patients receiving the 50 mg dose and levels of the major metabolite were much lower than expected and not different from those seen after 20 mg, suggesting saturation at the higher dose. We conclude that 20 mg seems a suitable dose of liquid melatonin in patients with sepsis.
- Open Access
- 5 August 2022
- Published by Springer Nature
Comparing two types of epidural for sciatica pain
- 5 August 2022
- Published by Springer Nature
Open AccessComparing two types of epidural for sciatica pain
- Open Access
- 30 July 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 122, 957-958
Lack of compliance with mandatory clinical trial registration
- 30 July 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 122, 957-958
Open AccessLack of compliance with mandatory clinical trial registration
- Open Access
- 10 March 2022
- Published by MDPI AG in Antioxidants
- Vol. 11 (3) , 532
Melatonin and Related Compounds: Antioxidant and Anti-Inflammatory Actions
Melatonin, an indoleamine derived from tryptophan and produced in the pineal gland and other tissues
- 10 March 2022
- Published by MDPI AG in Antioxidants
- Vol. 11 (3) , 532
Open AccessMelatonin and Related Compounds: Antioxidant and Anti-Inflammatory Actions
Melatonin, an indoleamine derived from tryptophan and produced in the pineal gland and other tissues
- Open Access
- 23 February 2022
- Published by Taylor & Francis in Physiotherapy Theory and Practice
- Vol. 39 (4) , 690-703
The effect of Preoperative threshold inspiratory muscle training in adults undergoing cardiac surgery on postoperative hospital stay: a systematic review
Systematic reviews have reported benefits of preoperative inspiratory muscle training in adults undergoing cardiac surgery, however there have been inconsistencies with the devices used. Threshold ...
- 23 February 2022
- Published by Taylor & Francis in Physiotherapy Theory and Practice
- Vol. 39 (4) , 690-703
Open AccessThe effect of Preoperative threshold inspiratory muscle training in adults undergoing cardiac surgery on postoperative hospital stay: a systematic review
Systematic reviews have reported benefits of preoperative inspiratory muscle training in adults undergoing cardiac surgery, however there have been inconsistencies with the devices used. Threshold ...
- Open Access
- 12 November 2021
- Published by SAGE Publications in British Journal of Pain
- Vol. 16 (3) , 281-289
Extent of sleep problems and relationship with severity of chronic pain using three validated sleep assessment tools
Chronic pain can impact on sleep, but the extent and nature of sleep problems in patients with chronic pain are incompletely clear. Several validated tools are available for sleep assessment but they each capture different aspects. We aimed to describe the extent of sleep issues in patients with chronic non-malignant pain using three different validated sleep assessment tools and to determine the relationship of sleep issues with pain severity recorded using the Brief Pain Inventory (BPI), a commonly used self-assessment tool in pain clinics. The BPI has a single question on the interference of pain on sleep and we also compared this with the validated sleep tools. Prospective, cross-sectional study. Pain management clinic at a large teaching hospital in the United Kingdom. Adult patients (with chronic non-malignant pain of at least 3 months’ duration) attending clinic during a 2-month period. Participants completed the Pittsburgh Sleep Quality Index (PSQI), the Pain and Sleep Questionnaire-3 (PSQ-3) and the Verran Snyder-Halpern (VSH) sleep scale, plus the BPI. Duration and type of pain, current medications and demographic data were recorded. We recruited 51 patients and 82% had poor sleep quality as shown by PSQIscores above five. PSQI (p = 0.0002), PSQ-3 (p = 0.0032), VSH sleep efficiency (p = 0.012), sleep disturbance (p = 0.0014) and waking after sleep onset (p = 0.0005) scores were associated with worse BPI pain scores. BPI sleep interference scores concurred broadly with the validated sleep tools. Median [range] sleep duration was 5.5 [3.0–10.0] hours and was also related to pain score (p = 0.0032). Chronic pain has a marked impact on sleep regardless of the assessment tool used. The sleep interference question in the BPI could be used routinely for initial identification of sleep problems in patients with chronic pain.
- 12 November 2021
- Published by SAGE Publications in British Journal of Pain
- Vol. 16 (3) , 281-289
Open AccessExtent of sleep problems and relationship with severity of chronic pain using three validated sleep assessment tools
Chronic pain can impact on sleep, but the extent and nature of sleep problems in patients with chronic pain are incompletely clear. Several validated tools are available for sleep assessment but they each capture different aspects. We aimed to describe the extent of sleep issues in patients with chronic non-malignant pain using three different validated sleep assessment tools and to determine the relationship of sleep issues with pain severity recorded using the Brief Pain Inventory (BPI), a commonly used self-assessment tool in pain clinics. The BPI has a single question on the interference of pain on sleep and we also compared this with the validated sleep tools. Prospective, cross-sectional study. Pain management clinic at a large teaching hospital in the United Kingdom. Adult patients (with chronic non-malignant pain of at least 3 months’ duration) attending clinic during a 2-month period. Participants completed the Pittsburgh Sleep Quality Index (PSQI), the Pain and Sleep Questionnaire-3 (PSQ-3) and the Verran Snyder-Halpern (VSH) sleep scale, plus the BPI. Duration and type of pain, current medications and demographic data were recorded. We recruited 51 patients and 82% had poor sleep quality as shown by PSQIscores above five. PSQI (p = 0.0002), PSQ-3 (p = 0.0032), VSH sleep efficiency (p = 0.012), sleep disturbance (p = 0.0014) and waking after sleep onset (p = 0.0005) scores were associated with worse BPI pain scores. BPI sleep interference scores concurred broadly with the validated sleep tools. Median [range] sleep duration was 5.5 [3.0–10.0] hours and was also related to pain score (p = 0.0032). Chronic pain has a marked impact on sleep regardless of the assessment tool used. The sleep interference question in the BPI could be used routinely for initial identification of sleep problems in patients with chronic pain.
- Open Access
- 27 August 2020
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 11, 872
Melatonin Is a Feasible, Safe, and Acceptable Intervention in Doctors and Nurses Working Nightshifts: The MIDNIGHT Trial
Nightshift working is associated with sleep deprivation, fatigue and attention/concentration deficits which, in healthcare workers, may impact on patient safety. Clinical staff in the UK routinely work several 12 h nightshifts in a row at about 1–3 month intervals. We investigated the feasibility and acceptability of a crossover trial of melatonin administration in clinical staff working nightshifts with an exploration of effects on sleep measures and attention/concentration tasks. This was a pilot, double-blinded, randomized, placebo-controlled crossover feasibility trial in doctors and nurses working 3 consecutive nightshifts at a tertiary referral hospital in the UK. Twenty five male and female subjects were randomized to receive either 6mg Circadin™ slow release melatonin or placebo before sleep after each consecutive nightshift, followed by a washout period, before crossing over to the other experimental arm. We used actigraphy for objective assessment of sleep parameters. The trial design was feasible and acceptable to participants with negligible side effects, but elevated melatonin levels were prolonged during the active arm (P=0.016). Double digit addition testing, a concentration/attention task, improved with melatonin treatment (PClinical Trial Registration: identifier ISRCTN15529655. https://www.isrctn.com/
- 27 August 2020
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 11, 872
Open AccessMelatonin Is a Feasible, Safe, and Acceptable Intervention in Doctors and Nurses Working Nightshifts: The MIDNIGHT Trial
Nightshift working is associated with sleep deprivation, fatigue and attention/concentration deficits which, in healthcare workers, may impact on patient safety. Clinical staff in the UK routinely work several 12 h nightshifts in a row at about 1–3 month intervals. We investigated the feasibility and acceptability of a crossover trial of melatonin administration in clinical staff working nightshifts with an exploration of effects on sleep measures and attention/concentration tasks. This was a pilot, double-blinded, randomized, placebo-controlled crossover feasibility trial in doctors and nurses working 3 consecutive nightshifts at a tertiary referral hospital in the UK. Twenty five male and female subjects were randomized to receive either 6mg Circadin™ slow release melatonin or placebo before sleep after each consecutive nightshift, followed by a washout period, before crossing over to the other experimental arm. We used actigraphy for objective assessment of sleep parameters. The trial design was feasible and acceptable to participants with negligible side effects, but elevated melatonin levels were prolonged during the active arm (P=0.016). Double digit addition testing, a concentration/attention task, improved with melatonin treatment (PClinical Trial Registration: identifier ISRCTN15529655. https://www.isrctn.com/
- Open Access
- 1 June 2020
- Published by MDPI AG in Antioxidants
- Vol. 9 (6) , 464
Reply to Comment on “Differential Effects of MitoVitE, α-Tocopherol and Trolox on Oxidative Stress, Mitochondrial Function and Inflammatory Signalling Pathways in Endothelial Cells Cultured under Conditions Mimicking Sepsis. Antioxidants 2020, 9(3), 195”
We thank Drs Hegarty and Byrne for their interest in our paper and appreciate the opportunity to respond to their insightful comments
- 1 June 2020
- Published by MDPI AG in Antioxidants
- Vol. 9 (6) , 464
Open AccessReply to Comment on “Differential Effects of MitoVitE, α-Tocopherol and Trolox on Oxidative Stress, Mitochondrial Function and Inflammatory Signalling Pathways in Endothelial Cells Cultured under Conditions Mimicking Sepsis. Antioxidants 2020, 9(3), 195”
We thank Drs Hegarty and Byrne for their interest in our paper and appreciate the opportunity to respond to their insightful comments